Sunitinib as a Second-line Treatment for Patients With Recurrent Small Cell Lung Cancer
Clinical trial NCT00620347 · COMPLETED
Trial details
- NCT number
- NCT00620347
- Sponsor
- National Cancer Center, Korea
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2012-02-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.